2m 2m 2m 2m 2m 2m 2m
CARIS (CAI)
NASDAQ
$17.58+$0.27 (+1.57%)
Price as of Jun 23, 2026 1:38 PM EDT- $4.9BMarket Cap
- -33.27%1-Year Change
- BiotechnologyIndustry
CARIS (CAI)
$17.58+$0.27 (+1.57%)
Annual
Quarterly
12/31/2025 | ||
|---|---|---|
Income Statement | ||
Total Operating Revenue | 766.7M N/A | |
Cost of Revenue | 262.4M N/A | |
Gross Profit | 504.4M N/A | |
Sales and Marketing Expense | 167.5M N/A | |
Research and Development Expense | -101.6M N/A | |
Depreciation and Amortization Expense | 22.6M N/A | |
Total Operating Expenses | 766.9M N/A | |
Operating Profit | 45.1M N/A | |
Interest Income | 16.5M N/A | |
Interest Expense | -56.8M N/A | |
Interest Income and Expense and Net | -40.3M N/A | |
Total Nonoperating Income and Expense | -113.2M N/A | |
Income before Taxes | -68.1M N/A | |
Income Taxes | 0 N/A | |
Extraordinary Items | N/A N/A | |
Net Income | -68.1M N/A | |
Net Income from Continuing Operations Applicable to Common | -538.0M N/A | |
Basic EPS and Net Income | -3.22 N/A | |
Diluted EPS and Net Income | -3.22 N/A | |
Basic Weighted Average Shares | 167.2M N/A | |
Diluted Weighted Average Shares | 167.2M N/A | |
Balance Sheet | ||
Cash and Cash Equivalents | 800.0M N/A | |
Short-Term Investments | 2.3M N/A | |
Cash and Cash Equivalents and Short-Term Investments | 802.3M N/A | |
Total Current Assets | 997.8M N/A | |
Accumulated Depreciation | 241.0M N/A | |
Property and Plant and Equipment and Net | 63.2M N/A | |
Total Long-Term Assets | 45.3M N/A | |
Total Assets | 1.1B N/A | |
Income Taxes Payable | N/A N/A | |
Total Short-Term Debt | 169,000 N/A | |
Total Current Liabilities | 127.1M N/A | |
Total Long-Term Debt | 378.8M N/A | |
Total Long-Term Liabilities | 42.4M N/A | |
Total Liabilities | 548.4M N/A | |
Retained Earnings | -2.5B N/A | |
Total Stockholders Equity | 577.3M N/A | |
Total Shares Outstanding | 282.5M N/A | |
Cash Flow | ||
Cash from Operating Activities | 83.2M N/A | |
Capital Expenditures | 16.3M N/A | |
Cash from Investing Activities | -16.3M N/A | |
Dividends Paid | N/A N/A | |
Cash from Financing Activities | 665.0M N/A | |
Financials Ratio | ||
Gross Margin | N/A N/A | |
Operating Margin | N/A N/A | |
Return on Assets | N/A N/A | |
Return on Equity | N/A N/A | |
Revenue Growth | N/A N/A | |
Current Ratio | N/A N/A | |
Cash Ratio | N/A N/A | |
Debt-to-Equity Ratio | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow